Replies to post #42045 on Kraig Biocraft Laboratories Inc (KBLB)

[manshoon1]

they politely attack KBLB and try to distinguish themselves by saying that their goal is pure spider silk, falsely implying that KBLB does not also have that goal.

THat was not the KBLB's goal. Kim said it explicitly!.... it is now b/c Kim believes ZFN's are capable of achieving that accomplishment.

Entogenetics is no longer a creditable competitor

We established that point in 2010 on this board.

This highlights the need for NDAs and "silent periods" to avoid giving too much information to competitors and to assure the granting of patents and the publication of new successes in the best peer reviewed scientific journals.

That is a subjective statement. Everyone agrees that certain info. is kept secret, but that does not mean you need a "silent period" in total.

Also, at some point in the next year or two, after the stock gets up to a dollar or more and perhaps shortly after it is listed on NASDAC or NYSE, We should expect a major "short and shred" attack complete with major negative publicity in an attempt to bring the company down and profit from its fall.

You predicted KBLB pps to reach 1 dollar by 2011 year end. The problem is the disparity between investor expectations and the reality. Kim does not want investors to know the reality of the situation. For KBLB to achieve a significant price appreciation as you have noted, there has to be serious accomplishments made, and obviously made public. I feel it is obvious that every single KBLB follower thinks this is taking much longer than originally anticipated.

There are many players of this game out there who are undoubtedly collecting all of the disparagement and conspiracy theories posted on this board.

The only thing that matters are the facts. This is Kim's baby, he has to be responsible for every decision he has made. If he comes under fire by "many players" for that, then I don't see that as being a problem. You reep what you sow. As long as KBLB is legitimate and has a legitimate product with legitimate potential, then KBLB will do just fine.

[ZincFinger]

I'm sure that with a random process like undirected homologous recombination (far more random than ND's piggyBac) Entogenetics realized that it's ONLY chance to win was to get the exclusive use of zinc fingers in silkworms. By getting that exclusive use for KBLB, Kim essentially won the race. (and that contract was what led me to invest in KBLB in the first place because I knew that having the exclusive use of zinc fingers would give KBLB an advantage that could not be overcome).

KBLB may (or may not) have ultimately succeeded without the use of zinc fingers IF, and only if, no one else was using them either. But it would have taken a lot longer, success would have been problematical and KBLB would have experienced a lot more dilution along the way.

PS: the reason my screen name is "zincfinger" has nothing to do with KBLB: I've been long on SGMO since 2000 and have followed the development of zinc fingers very closely. They will utterly transform the field of biotechnology and KBLB will be at the leading edge of the new wave. Kudos to Kim for getting the deal with SIAL!

[peach_schnapps]

Mike -

i owe you an apology. my post from friday was not meant to egg on manshoon, so i'm sorry if i escalated the battle of wills.

i hope this finds you well, and enjoy the weekend.